Skip to content

The Effect of Activated Vitamin D on treatment of Acute Kidney injury

The Effect of Activated Vitamin D on treatment of Acute Kidney injury

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181010041299N2
Enrollment
76
Registered
2019-10-31
Start date
2019-09-23
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Failure. Acute renal failure with tubular necrosis

Interventions

Intervention 1: Intervention group: The case group received 0.25 mg rocanrolol tablets, except for routine renal injury treatment. Intervention 2: Control group: patients will receive no medication ot

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Ages over 18 years Acute kidney failure according to KDIGO criteria Having informed consent to participate in the study Hospitalized in the usual ward, ICU CCU of Imam Hossein Shahrood Hospital Non-return of creatinine to normal within 48 hours despite fluid replacement or granular and epithelial casts Ability to eat or own NG Tube No history of kidney disease and kidney transplant No history of taking vitamin D compounds for the past 7 days No active primary parathyroid disease or active granulomatous disease or symptomatic nephrolithiasis in the past 3 months No pregnancy no breastfeeding

Exclusion criteria

Exclusion criteria: Get cytochrome p450 inhibitor drugs Hemoglobin less than 7

Design outcomes

Primary

MeasureTime frame
Evaluation of kidney function. Timepoint: Daily. Method of measurement: blood test.;Urea. Timepoint: Daily. Method of measurement: blood test.;Creatinine level. Timepoint: Daily. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Asie Emmett Mohammadi

Shahroud University of Medical Sciences

asyomat@gmail.com+98 23 3239 5009

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026